Advertisement
Screener

Edwards Lifesciences Corporation (EW) Outstanding Bonds: Outstanding

Edwards Lifesciences Corporation Outstanding Bonds

Note series still outstanding, nearest maturity first. Terms are from each offering's final pricing term sheet on SEC EDGAR; a reopening of the same CUSIP adds to its principal. Interest per payment = principal × coupon ÷ payments per year. Outstanding = principal issued minus each filed exchange, tender, redemption or conversion; it is (m) where the retired amount was not filed. Interest per payment uses the outstanding principal.

  • 4.300% Notes due 2028: Principal issued $600.00M; Outstanding $600.00M; Coupon 4.30%; Trade date 2018-06-06.
NotesPrincipal issuedOutstandingCouponTrade dateIssue / settlement dateMaturity dateInterest payment datesInterest per paymentAnnual coupon interestOptional redemptionRetiredPriced
4.300% Notes due 2028
CUSIP 28176EAD0
$600.00M$600.00M4.30%2018-06-062018-06-152028-06-15Semi-annually: June 15, December 15
30/360
$12.90M$25.80MMake-whole: Treasury + 25 bps2018-06-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00